A portfolio of essential medicines
Azactam®
Dosages and presentations
AZACTAM® 1 g. Powder for parenteral use.
Box of 1 vial. Box of 10 vials.
AZACTAM® 2 g. Powder for parenteral use.
Box of 1 vial
(Not all dosages and packagings are available in all countries)
Box of 1 vial. Box of 10 vials.
AZACTAM® 2 g. Powder for parenteral use.
Box of 1 vial
(Not all dosages and packagings are available in all countries)
Product information - Patient information leaflet
- Austria
- Australia
- Belgium, Luxemburg
- Finland
- France
- Ireland
- New Zealand
- Norway
- Portugal
- Romania
- Singapore
- Spain
- Sweden
- Switzerland
Active ingredient
Aztreonam
Marketing
- Austria (dosage 1g, 2g. box of 1 vial)
- Australia (dosage 1g, box of 10 vials)
- Belgium, Luxemburg (dosage 1g, 2g, box of 1 vial)
- Finland (dosage 1g, 2g. box of 1 vial)
- France (dosage 1g, box of 1 vial)
- Ireland (dosage 1g, 2g, box of 1 vial)
- New Zealand (dosage 1g, box of 10 vials)
- Norway (dosage 2g, box of 1 vial)
- Portugal (dosage 1g, box of 1 vial)
- Romania (dosage 1g, box of 1 vial)
- Singapore (dosage 1g, box of 1 vial)
- Spain (dosage 1g, box of 1 vial)
- Sweden (dosage 1g, 2g. box of 1 vial)
- Switzerland (dosage 2g, box of 1 vial)
- United Kingdom (dosage 1g, 2g, box of 1 vial)
- United States (dosage 1g, 2g, box of 10 vials)
Product news
Product available
This information is intended for healthcare professionals.
Our therapeutic areas
and our main products
Infectiology
Amikacin
Aztreonam
Amoxicillin
Xyllomac®
(France)
Amoxicillin Delbert®
(Ireland)
Delamoxyle®
(Belgium - Luxembourg)
Delamoxyl®
(Switzerland)
Amoxicillin and clavulanic acid
Benzathine benzylpenicillin
Extencilline®
(France - Switzerland)
Extencin®
(Netherlands)
Benzylpenicillin benzathine
(United Kingdom)
Oxacillin
Istopen®
(France)
Penstapho®
(Italy)
Prostaphlin®
(Czech Republic)
Central nervous system
Lithium carbonate
Tropatépine hydrochloride
Pipotiazine palmitic ester
Lorazepam
Some of our products may be available internationally through our distributors, under different trade names. Please contact us to find out more.
REQUEST MEDICAL INFORMATION - REPORT AN ADVERSE EVENT
To request medical information on Delbert Pharma products or report an adverse event,
please write to pharmacovigilance@delbert.fr or contact us on + 33 1 46 99 68 20.
